INESSS: Recherche

17391 à 17400 de 19830 résultats

Document | Usage optimal

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Pertinence:

4%

1 / 9 INTERACTIONS MÉDICAMENTEUSES AVEC LES ANTICOAGULANTS ORAUX DIRECTS SOMMAIRE DES INTERACTIONS Apixaban Édoxaban Rivaroxaban Dabigatran AGENTS ANTI-INFECTIEUX SYSTÉMIQUES Antibactériens (macrolide

Type de fichier: application/pdf
Référencé à:

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Document | Usage optimal

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Pertinence:

4%

1 / 9 INTERACTIONS MÉDICAMENTEUSES AVEC LES ANTICOAGULANTS ORAUX DIRECTS SOMMAIRE DES INTERACTIONS Apixaban Édoxaban Rivaroxaban Dabigatran AGENTS ANTI-INFECTIEUX SYSTÉMIQUES Antibactériens (macrolide

Type de fichier: application/pdf
Référencé à:

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Document | Usage optimal

Clinical tool - Dialogue with your patient

Pertinence:

4%

1. For information on shared decision-making with your patient, view the video clip on our website inesss.qc.ca. 1 / 4 In what situations should this dialogue be initiated? • When consideration is bei

Type de fichier: application/pdf
Référencé à:

Clinical tool - Dialogue with your patient

Abonnez-vous à notre infolettre dès maintenant